Subcutaneous Biologics, Technologies and Drug Delivery Systems (3rd Edition), 2020-2030

CORTLANDT MANOR, N.Y. - Nov. 23, 2020 - PRLog -- The report provides a detailed study on the current market landscape and future potential of biologics designed for subcutaneous administration. In addition, the study provides an in-depth analysis of the formulation technologies and drug delivery systems (focusing on large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants) that enable subcutaneous delivery of the biologic drugs. Amongst other elements, the report features the following:

§  A detailed assessment of the current market landscape of commercially available and clinical-stage biologics that are designed for delivery via the subcutaneous route

§  A case study on leading subcutaneous biologics (in terms of revenues generated), featuring details on mechanism of action, development history, annual sales, technology platform (if available), and a comparison of their intravenous and subcutaneous formulations (if applicable).

§  An assessment of the various subcutaneous formulation technologies along with information on developers, type of pharmacological molecule, route of administration, mechanisms of action and primary advantage(s).

§  An analysis of collaborations  and partnership agreements inked by the subcutaneous formulation technology developers since 2011

§  An in-depth review of the most advanced and popular subcutaneous drug delivery systems, including large volume wearable injectors, autoinjectors, pen injectors, needle-free injectors, drug reconstitution systems, prefilled syringes and implants

§  A comprehensive product competitiveness analysis of subcutaneous large volume wearable injectors, subcutaneous autoinjectors, subcutaneous needle-free injectors and pre-filled syringes

§  A discussion on affiliated trends, key drivers and challenges, which are likely to impact the industry's evolution, under a comprehensive SWOT framework

§  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):

§  Phase of development

§  Approved

§  Pre-registration & Phase III

§  Phase II & Phase II/III

§  Type of molecule

§  Cell and gene therapies

§  Monoclonal antibodies

For additional details, please visit

https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html

Other Recent Offerings

1.      Global Autoinjectors Market (3rd Edition), 2020-2030 (https://www.rootsanalysis.com/reports/view_document/autoi...)

2.      Prefilled Syringes Market (5th Edition), 2020-2030 (https://www.rootsanalysis.com/reports/view_document/prefi...)

3.      Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030

4.      Large Volume Wearable Injectors Market (4th Edition), 2018-2030

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com